English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 16 April 2024, 17:04 HKT/SGT
Share:
    

Source: Autonomix Medical Inc.
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
Company is targeting pancreatic cancer pain with advanced nerve detection and treatment technology

NEW YORK, Apr 16, 2024 - (ACN Newswire) - A new article on Autonomix Medical Inc. (NASDAQ: AMIX), featuring the company's groundbreaking approach to peripheral nervous system (PNS) disorders, has been published by Benzinga. The Benzinga article delves into the critical role of the PNS in human health and highlights how Autonomix Medical is pioneering with its catheter-based microchip sensing array technology.

The article provides a comprehensive look at how Autonomix Medical is redefining treatment protocols for nerve-related disorders. By targeting the root causes associated with the PNS, rather than just managing symptoms, Autonomix Medical's technology offers a novel solution that combines both detection and ablation of problematic nerves in a single procedure. This approach, likened to a "GPS" for nerve treatment, allows for precise identification and treatment of the nerves involved, enhancing the accuracy and effectiveness of procedures.

In a notable application, the company is focusing its efforts on managing pancreatic cancer pain — a condition notoriously difficult to treat due to its proximity to critical nerves. The technology's high sensitivity in detecting neural signals—up to 3,000 times greater than existing technologies — promises not only to improve outcomes in pain management but also to significantly reduce the need for opioids, addressing a major public health challenge.

This exposure in Benzinga underscores the potential of Autonomix Medical's technology to transform the field of electrophysiology and pain management, potentially tapping into a market exceeding $100 billion. As the company progresses with its clinical trials, the successful implementation of its technology could revolutionize treatment approaches for a wide range of diseases, offering hope to millions of patients worldwide.

To read the full article, click here.

More Pancreatic Cancer News:

  • Candel Therapeutics, Inc. ((Nasdaq: CADL) announced that the FDA has granted Orphan Drug Designation to their advanced biological immunotherapy, CAN-2409, for treating pancreatic cancer, following promising phase 2 clinical trial results that more than doubled median overall survival when added to standard care.
  • RenovoRx, Inc. (Nasdaq: RNXT) announced an $11.1 million private placement, extending their financial runway into 2026, which will support the continuation and completion of their pivotal Phase III TIGeR-PaC clinical trial for pancreatic cancer. This funding also facilitates the expansion of their Trans-Arterial Micro-Perfusion (TAMP) clinical development pipeline into additional cancer indications.

Note: The details provided in this press release are based on information featured in the Benzinga article and do not constitute forward-looking statements.

For more information, contact:
Plato Data Intelligence
144 E44th St
New York NY 10017
PlatoAiStream.com
Zephyr@platodata.io

 



Topic: Press release summary
Source: Autonomix Medical Inc.

Sectors: Healthcare & Pharm, MedTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Domino's Pizza Inc. Is Being Investigated by Kaplan Fox & Kilsheimer LLP for Potential Securities Law Violations  
July 26, 2024 23:30 HKT/SGT
CORRECTION FROM SOURCE: Doubleview Reports Maiden Mineral Resource Estimate  
July 26, 2024 21:00 HKT/SGT
CITIC Resources Announces its 2024 Interim Results  
July 26, 2024 20:43 HKT/SGT
OmniGuide Holdings Announces Successful Completion of Patient Study for Revolutionary iSTONE(TM) Laser-Guided Lithotripsy Technology  
July 26, 2024 20:05 HKT/SGT
VCI Global Enters into AI Computing Alliance (AICA) Led by Enlight Corporation and Supermicro  
July 26, 2024 20:00 HKT/SGT
DOCOMO and NTT Com Jointly Demonstrate Practicality of DOCOMO's New Multi-platform Cloud-rendering Technology  
Friday, July 26, 2024 4:05:00 PM
Kucingko Berhad Debuts on ACE Market with Clawsome Opening Price of RM0.805  
July 26, 2024 15:00 HKT/SGT
British Veterinary Association Ends Opposition to Vegan Diets for Dogs  
July 26, 2024 02:00 HKT/SGT
TANAKA Precious Metals Provided Award Items and Ceremony Souvenirs for the International Friendly Matches of the Japan Men's National Blind Football Team at the "DAICEL Blind Football Japan Cup 2024 in Osaka" on July 7  
Friday, July 26, 2024 2:00:00 AM
An off-site session of the Eastern Economic Forum was held in Hong Kong  
July 25, 2024 21:46 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575